SEC $22mn for Pharma Bribery

On Sep. 4, SEC issued $25mn settlement with Sanofi for bribery.

  • Paris-based company Sanofi was charged for corrupt payments to win business.

Alleged Violations

  • Schemes in multiple countries and involved bribes to government procurement
    officials and healthcare providers to be awarded tenders and buy prescriptions.
  • In Kazakhstan, used distributors as part of kickback scheme to generate funds.
  • Tracked kickbacks in internal spreadsheets where they were coded as marzipan.
  • In Middle East, pay-to-prescribe schemes, used to induce healthcare providers.


  • $17.5mn disgorgement, $2.7mn in prejudgment interest, and penalty of $5mn.